Hepatocellular carcinoma
Conditions
Interventions
Therapeutic Group:TACE combined with ablation and/or SBRT radiotherapy
Sponsors
Gaoxin Branch of The First Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: (1) Patients with hepatocellular carcinoma who are pathologically or meet clinical diagnostic criteria; (2) Patients with stage IIB-IIIB hepatocellular carcinoma; (3) Patients who have not been systematically treated with targeted therapy, immunotherapy, chemotherapy, etc.
Exclusion criteria
Exclusion criteria: (1) 80 years old; (2) Liver function Child grade C and B patients with >8 points; (3) Patients with severe cardiopulmonary, kidney and coagulation dysfunction; (4) Patients with history of esophageal and gastric varices bleeding; (5) pregnant women and patients with mental illness, or other conditions can not cooperate with the implementation of medical treatment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival;The frequency and severity of adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Objective response rate;Disease control rate; | — |
Countries
China
Contacts
Public ContactKe Fang
Gaoxin Branch of The First Affiliated Hospital of Nanchang University
Outcome results
None listed